POET Technologies: $830 Million Cash Hoard Fails to Halt a 61% Slide as Legal and Execution Hurdles Pile Up

Despite $830M in cash and a $500M Lumilens deal, POET's stock crashes 61% from May peak as legal battles, customer cancellations, and heavy losses spook investors.

POET Technologies has stuffed its coffers with more than $830 million in fresh equity over the past twelve months, yet the stock has shed over 61% from its May 2026 peak. The disconnect between the company’s ambitious production timeline and the market’s mounting concerns over legal disputes, customer cancellations, and ongoing losses has turned the Canadian chip specialist into one of the most volatile names in the optical infrastructure space.

The cash position, which stood at over $830 million in cash and short?term investments as of June, is earmarked for a production ramp?up that the company insists remains on schedule. Roughly $50 million is specifically reserved for manufacturing equipment to support a production start in the second half of 2026. POET plans to ship more than 30,000 optical engines next year and reach a capacity of one million units per month by the end of 2027. To fund that growth, it has expanded clean rooms, added office space, and grown its headcount to around 115 employees.

Strategic Partnerships vs. Revenue Reality

A crucial pillar of POET’s growth story is a supply agreement with Lumilens, announced on May 14. The initial purchase order is worth $50 million, and over five years the deal could cumulatively generate more than $500 million in revenue. That same day, the company also reported first?quarter results: revenue of just $503,389 and a net loss of $12.3 million. The yawning gap between the Lumilens promise and the current financial reality underscores the execution risk.

Separately, POET has highlighted a cooperation with Lessengers, a partner expected to help convert product demonstrations into volume orders from AI and data?center clients. The challenge remains that while the industry is awash with prototypes, firm large?scale purchase commitments are far harder to secure.

Legal Overhang and a Pulled Order

Investor confidence took a direct hit in April when Marvell Semiconductor cancelled all existing purchase orders from Celestial AI, citing alleged breaches of confidentiality. The cancellation sent the stock sharply lower, and its effects are still weighing on sentiment. Compounding the pressure, multiple class?action lawsuits have been filed against POET and certain executives, accusing them of making false or misleading statements about the company’s tax status and the circumstances surrounding the Marvell cancellation.

On top of the legal cloud, the company’s heavy reliance on equity financing continues to dilute shareholders even as losses persist. The $400 million registered direct placement completed on May 18 — 19,047,620 common shares plus warrants at a combined price of $21 per unit — was part of the $830 million total but added to the share count considerably.

Stock in Freefall, Yet a Technical Signal Appears

The share price closed recently at €7.29, down 33.12% over the past 30 days and 61.31% from the 52?week high of €18.84 set on May 15. Despite the sell?off, the stock remains up 114.41% from its November 2025 low of €3.40 and has gained 27.89% over the trailing twelve months. The annualized volatility of 115.75% tells the real story: a furious, unforgiving ride.

On the technical front, some analysts identified a bull?flag formation on July 15, a pattern that historically signals a short?term rebound with a target of $9.10 (€8.35). The 14?day relative strength index sits near 40, approaching oversold territory but not yet at extreme levels. The stock now trades well below its 50?day moving average of €10.35 and its 100?day average of €8.25, though it holds just above the 200?day line of €6.87. The current market capitalization stands at roughly €417 million.

For POET, the near?term direction hinges on whether it can translate the Lumilens and Lessengers partnerships into actual revenue before the legal battles further erode confidence. The bull?flag pattern suggests a potential bounce, but until production begins in the second half of 2026 — and the company proves it can execute at scale — the stock remains a high?wire act for all but the most risk?tolerant investors.